|

A Novel Immune Modulator EpiCor™
FAQ Frequently Asked Questions About
By Chris D. Meletis, ND
EpiCor™ is a revolutionary new product that has been researched for its
effects on the immune system. The response has been tremendous. However, there
have also been many questions that have arisen. I have studied the research that
exists on EpiCor and would now like to address the most frequently asked
questions about this intriguing new product.
Q. Is EpiCor™ an immune stimulant?
A. It is most accurate to describe EpiCor as an immune modulator. It has an
unique ability to help regulate the human body’s natural immune defenses. This
effect is nicely illustrated by its ability to increase CD4 (helper) and
decrease CD8 (suppressor) cells. This leads to an up regulation of natural
defenses as the direct consequence of the CD4 cells increasing immunological
responsiveness. Likewise, the effect of EpiCor on Natural Killer (NK) cells is
intriguing. Rather than increasing the number of NK cells, EpiCor strategically
enhances NK activity. The net result of both enhanced NK cell activity and an
improved CD4/CD8 ratio is the creation of an augmented immune competency.
Q. Can a person battling Candida albicans take EpiCor™ since it is derived from
yeast?
A. The yeast that EpiCor™ is derived from is common baker’s yeast. Having worked
with patients with yeast sensitivity and those addressing Candida albicans
infections, I do not routinely find a significant cross reactivity with
yeast-derived substances. Certainly, the potential is theoretically present for
a few select individuals to experience reactivity symptoms, yet I have not found
this to be the case in clinical practice. In fact, experts in the field believe
that the likelihood for reactivity is minimal, otherwise the ubiquitous nature
of baker’s yeast would cause reactivity in the populace on an ongoing basis.
EpiCor is such a powerful immune modulator that it would most likely benefit
most individuals suffering from candidiasis.
Q. Is there an application for autoimmune disease?
A. There is great promise that via EpiCor’s immunomodulator effect that the
hyper-reactivity experienced by an individual with such conditions may become
moderated.
Many of the traditional prescription medications used to help control the
symptoms of these conditions are targeted at suppressing the immune system
responsiveness. The evidence points to EpiCor’s ability to increase the
efficiency of inherent immunomodulatory processes in the body. Thus, a trial of
EpiCor while being monitored by a personal physician seems reasonable. In my
clinical practice, I recommend that all my patients with autoimmune disease take
a food allergy test as well. By identifying and eliminating food
allergens/sensitivities the immune irritants that could otherwise up regulate
immune reactivity can be avoided.
Q. Does EpiCor have a direct effect on sIgA?
A. There is clear evidence that EpiCor is effective in killing Candida
tropicalis and E. coli. As to whether it will kill Candida albicans is yet to be
studied. Yet its ability to improve immune competence and enhance sIgA (secretory
IgA) points to a strong potential positive effect. It is important to note that
sIgA serves as the equivalent of an “immunological Scotchguard™,” protecting
mucous membranes from invasion by opportunistic infectious agents whether they
take the form of yeast, virus or bacteria.
Q. Is EpiCor the same as the animal feed product upon which it was based?
A. No it is not. The fermentation technology is similar but the drying systems
are completely different which produces a different metabolite profile. EpiCor
is designed to maximize the antioxidant activity and not damage any metabolites.
The company that developed EpiCor spent years taking what they knew on the
animal side to develop a product for humans. This is why humans only have to
take 500 mg while animals consume 2-4 ounces.
Q. Could EpiCor be taken daily to help minimize risk of colds and flus?
A. The reality is that the best defense is a good offense. This is particularly
true with EpiCor, which is meant to be taken every day to help the immune system
over time. EpiCor’s ability to increase sIgA can help envelope mucous membranes
and make them more impervious to potential pathogens. Also the improved CD4/CD8,
helper/suppressor cell ratio is a powerful shift to improve the immune system’s
ability to defend and cope with infectious agents. Evidence suggests that EpiCor
helps modulate the immune system over time. Furthermore, clinical tests and cell
culture studies have confirmed EpiCor’s long-term safety. I personally take 1
EpiCor per day as part of my overall immune support and for its other beneficial
effects.
Taking proactive steps is essential to staying well. Some other tips that are
foundationally important include washing ones hands regularly especially before
eating or touching ones face, and staying properly hydrated throughout the day.
Q. EpiCor’s ability to favorably shift CD4/CD8 cells suggests an application
worth considering when dealing with a viral burden on the body. Is this correct?
A. Yes. The improved CD4/CD8 ratio is precisely what is desired for those
dealing with a viral burden, as this ratio is often disrupted in this group.
There is no research specifically done in this area yet. However, it certainly
seems as if EpiCor would be a tool worth strong consideration.
Q. What role can EpiCor play in a regimen designed for free radical defense?
A. EpiCor is rich in catechins, phenolics, resveratrol and other potent
antioxidants. It is this natural blend that confers powerful free radical
quenching properties. Researchers discovered the ROS (reactive oxygen species)
quenching ability of EpiCor went as low as 1 part per trillion, which further
reflects EpiCor’s very high ORAC (free-radical-fighting) rating.
Q. Can EpiCor support gastrointestinal health?
A. Yes, EpiCor has been shown to kill E.Coli and also Candida tropicalis.
Additionally, EpiCor serves as a prebiotic, thus supporting healthy
gastrointestinal flora. Beyond these direct effects, the increase in the sIgA
that helps protect and envelope mucous membranes confers a significant level of
protection against invading microbes.
Q. Children’s immune systems must be exposed to bacteria, viruses etc. in order
to mature and mount a strong defense. If EpiCor prevents children from being
exposed to pathogens will it also prevent their immune systems from developing
properly?
A. As parents, we all have to make health choices for our kids. I have two
children myself, and have no problem giving EpiCor to them. EpiCor is derived
from an item that is ubiquitous in our daily lives. It works with the immune
system to modulate its actions. Children are great at picking up germs at school
and play. Consequently, EpiCor’s ability to enhance IgA, building an
immunological envelop and coating mucous membranes to help protect them from
excess burdens, would be highly beneficial to children and better help develop
their immune systems.
Highly recommended
trusted source of supplements.
How
did we qualify VRP?
Binaural Beat
Brainwave Entrainment Audio Technology
| Advanced Human Biochemical
Enhancement
|